United States · FDA National Drug Code directory
Quetiapine Fumarate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 34908-639_781f6242-bc94-424b-be23-ea9eb61c0889
- Product NDC
- 34908-639
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- quetiapine fumarate
- Labeler
- Novast Laboratories, Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170831
- Source listing expiry
- 20261231
Source-listed ingredients
- QUETIAPINE FUMARATE — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-639-10) · 34908-639-10
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-639-30) · 34908-639-30
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-639-60) · 34908-639-60
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (34908-639-90) · 34908-639-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →